Our Partners
Paul is a lawyer and economist who has represented parties before the US Department of Justice (DOJ), the Federal Trade Commission (FTC), and the State Attorneys General on the antitrust aspects of M&A, joint ventures, distribution and intellectual property arrangements, and other competitive conduct. Paul brings more than 35 years of M&A experience to our commercial assessments.
Mark is a business development expert and corporate strategist with experience in a number of biotechnology segments, including key market verticals in drug discovery, cell & gene therapy, and medical devices. Mark brings 7 years of academic and industry experience in biotechnology and pharmaceutical processes to our technical assessments.